2012 Value of Generic Drugs Symposium: Maximizing Employer Savings

Generic drug prices are falling and usage is on the rise. But are plan sponsors taking full opportunity of the potential savings by maximizing the use of generic drugs?

Coverage of the 2012 Value of Generic Drugs Symposium delves into this question, while also examining Canada’s drug review system and provincial drug pricing policies.

New controversial couponing practices are discussed, and a case study offers valuable lesson in how to introduce a generic substitution policy.